Astria Therapeutics
ATXS
ATXS
106 hedge funds and large institutions have $310M invested in Astria Therapeutics in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-9
Holders Change %
-7.83%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
44
Reduced
31
Closed
23
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$66K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$8.9M |
| 2 |
Millennium Management
New York
|
+$7.16M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.09M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.14M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$1.83M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$27.3M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.85M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.56M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$2.1M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.44M |